SCHEMBL2359233

SCHEMBL2359233

CCCCOC(=O)OB(O)c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 6/20 0.50
TDP1 Q9NUW8 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
ALDH1A1 P00352 3/20 0.46
MAPK1 P28482 3/20 0.46
CYP3A4 P08684 3/20 0.46
TP53 P04637 1/20 0.45
PCSK9 Q8NBP7 1/20 0.45
HSD17B10 Q99714 1/20 0.44
LMNA P02545 4/20 0.44
ELANE P08246 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
ESR1 P03372 1/20 0.41
CYP2D6 P10635 1/20 0.41
NR1H2 P55055 1/20 0.41
RNASEL Q05823 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5770681 0.88 CA1 (0.43) TSHRTDP1L3MBTL1ALDH1A1MAPK1
SCHEMBL1237692 0.83 TSHR (0.44) TSHRL3MBTL1ALDH1A1HSD17B10LMNA
SCHEMBL16150457 0.83 ELANE (0.42) TSHRTDP1L3MBTL1ALDH1A1MAPK1
SCHEMBL17493149 0.83 TSHR (0.43) TSHRTDP1L3MBTL1ALDH1A1MAPK1
SCHEMBL28664851 0.79 TRPV6 (0.44) TSHRL3MBTL1ALDH1A1MAPK1PCSK9
SCHEMBL1063089 0.78 TDP1 (0.46) TSHRTDP1L3MBTL1ALDH1A1MAPK1
SCHEMBL1128562 0.76 PCSK9 (0.58) TSHRTDP1L3MBTL1ALDH1A1MAPK1
SCHEMBL1237722 0.76 ALDH1A1 (0.53) TDP1L3MBTL1ALDH1A1MAPK1HSD17B10
SCHEMBL8727025 0.76 MAPT (0.49) TDP1L3MBTL1ALDH1A1LMNAMEN1
Phenol SCHEMBL2362180 0.75 TSHR (0.59) TSHRTDP1L3MBTL1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349223-A2 DOSAGE UNITS OF 3-(6-(1-(2,2-DIFLUOROBENZO [D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID Vertex Pharmaceuticals Incorporated (US) 2011-08-03 EP disclosed
WO-2009034390-A1 HETEROCYCLIC DERIVATIVES AND THEIR USE IN TREATING HEPATITIS C ARROW THERAPEUTICS LIMITED (GB) 2009-03-19 WO disclosed
EP-2029579-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-03-04 EP disclosed
EP-2021336-A2 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2009-02-11 EP disclosed
WO-2007127688-A2 INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-08 WO disclosed
WO-2007124254-A2 CYCLOHEXYLPYRAZOLE-LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY (US) 2007-11-01 WO disclosed
EP-1828180-A1 1H-PYRROLO[2,3-BETA]PYRIDINES SMITHKLINE BEECHAM CORPORATION (US) 2007-09-05 EP disclosed
WO-2006063167-A1 1H-PYRROLO[2,3-B]PYRIDINES SMITHKLINE BEECHAM CORPORATION (US) 2006-06-15 WO disclosed